Verification evidence is still being completed.
PDF / print export
Gensinta UAB
Vilnius, Lithuania
- Verified lead
- Benas Macijauskas
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Synthetic Biology, Photonics-Based DNA Synthesis, and Next-Generation Genomics Tools
- Review cycle
- 24 April 2026
- Full address
- Vilnius City Innovation Industrial Park (Northtown), Vilnius, Lithuania
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Northtown Vilnius announcement naming Benas Macijauskas as CEO of Gensinta.
- Editorial note
- Vilnius synthetic biology startup with named CEO, Northtown Innovation Industrial Park tenancy, and photonics-based DNA synthesis technology.
Synthetic Biology, Photonics-Based DNA Synthesis, and Next-Generation Genomics Tools
LithuaniaBIO association member, Vilnius City Innovation Industrial Park tenancy, Public CEO disclosure
Vilnius synthetic biology startup with named CEO, Northtown Innovation Industrial Park tenancy, and photonics-based DNA synthesis technology.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated07 Jul 2026, 01:10
Vilnius synthetic biology startup with named CEO, Northtown Innovation Industrial Park tenancy, and photonics-based DNA synthesis technology.
Contact & location
- Website
- lithuaniabio.com
- Lead
- Benas Macijauskas (verified ↗)
- Compliance
- Not yet on record
- Last reviewed
- 24 Apr 2026 (2mo ago)
- Scale
- Synthetic biology tools R&D
- Capabilities
- New-Generation DNA Synthesis · Molecular Biology and Photonics Integration · Synthetic Biology R&D
- Founded
- 2019
- Headcount
- 1-10
Synthetic Biology, Photonics-Based DNA Synthesis, and Next-Generation Genomics Tools
Vilnius synthetic biology startup with named CEO, Northtown Innovation Industrial Park tenancy, and photonics-based DNA synthesis technology.
Editorial note
Gensinta is a Vilnius synthetic biology startup with a named CEO, Vilnius City Innovation Industrial Park tenancy, and active LithuaniaBIO association membership.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Verification details
Clinical profileSTATUS: VERIFIED APRIL 2026
Benas Macijauskas
Chief Executive Officer
Full addressVilnius City Innovation Industrial Park (Northtown), Vilnius, Lithuania
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Synthetic biology tools R&D
Vilnius, Lithuania. Synthetic Biology, Photonics-Based DNA Synthesis, and Next-Generation Genomics Tools. Review completed on 24 Apr 2026.
Lithuanian innovation authorities for startup support
LithuaniaBIO association member, Vilnius City Innovation Industrial Park tenancy, Public CEO disclosure
Capabilities
New-Generation DNA Synthesis
Molecular Biology and Photonics Integration
Synthetic Biology R&D
Sources
The official sources used to verify this profile.
Infrastructure
DNA synthesis platform
Photonics integration workflow
Innovation Industrial Park tenancy
Certifications
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Review log
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
Frequently asked questions
- Where is Gensinta UAB located?
- Gensinta UAB operates from Vilnius City Innovation Industrial Park (Northtown), Vilnius, Lithuania, Vilnius, Lithuania.
- Who runs Gensinta UAB?
- Gensinta UAB is led by Benas Macijauskas, Chief Executive Officer. Verified 24 Apr 2026.
- What does Gensinta UAB do?
- Vilnius synthetic biology startup with named CEO, Northtown Innovation Industrial Park tenancy, and photonics-based DNA synthesis technology. Core capabilities: New-Generation DNA Synthesis, Molecular Biology and Photonics Integration, Synthetic Biology R&D.
Editorial context
Related technical briefs
Briefs that name Vilnius as a covered market or city.